SLC5A2 and diabetes mellitus: Non-additive effects between genetic CETP and SGLT2 inhibition on diabetes risk are not detected, as the interaction term is not significantly associated with diabetes risk (Estimate: −0.00233; 95% CI: −0.008 to 0.004; p-value=0.454) (Supplement 9).